Advertisement

Toxicant-Induced Hematologic Syndromes

  • Steven C. Curry
  • A. Min Kang
Reference work entry

Abstract

Oxidant hemolysis, methemoglobinemia, and sulfhemoglobinemia share common etiologies and frequently coexist in the same patient.

Keywords

Oxidant stress Heinz bodies Methemoglobinemia Sulfhemoglobinemia Hemolysis Dapsone Hexose monophosphate shunt Erythrocytes Bite cells Glutathione Arsine Chlorates Copper sulfate Haptoglobin NADPH methemoglobin reductase Methylene blue Congenital methemoglobinemia Benzocaine Prilocaine Phenazopyridine Nitrates Nitrites Well-water methemoglobinemia Aniline dyes Co-oximeters Co-oximetry Ascorbic acid 

References

  1. 1.
    Evans AS, Enzer N, Eder HA, Finch CA. Hemolytic anemia with paroxysmal methemoglobinemia and sulfhemoglobinemia; report of 2 cases. Arch Intern Med (Chic). 1950;86(1):22–34.CrossRefGoogle Scholar
  2. 2.
    Basset P, Bergerat JP, Lang JM, Oberling F, Gillet B. Hemolytic anemia and sulfhemoglobinemia due to phenacetin abuse: a case with multivisceral adverse effects. Clin Toxicol. 1981;18(4):493–9.CrossRefPubMedGoogle Scholar
  3. 3.
    Yoo D, Lessin LS. Drug-associated “bite cell” hemolytic anemia. Am J Med. 1992;92(3):243–8.CrossRefPubMedGoogle Scholar
  4. 4.
    Curry S. Methemoglobinemia. Ann Emerg Med. 1982;11(4):214–21.CrossRefPubMedGoogle Scholar
  5. 5.
    Weatherall DJ, Clegg JB, Higgs DR, et al. The hemoglobinopathies. In: Scriver CR, Beaudet AL, Sly WS, et al., editors. The metabolic basis of inherited disease. New York: McGraw-Hill; 1995. p. 3417–84.Google Scholar
  6. 6.
    Melzer-Lange M, Walsh-Kelly C. Naphthalene-induced hemolysis in a black female toddler deficient in glucose-6-phosphate dehydrogenase. Pediatr Emerg Care. 1989;5(1):24–6.CrossRefPubMedGoogle Scholar
  7. 7.
    Steffen C, Seitz R. Severe chlorate poisoning: report of a case. Arch Toxicol. 1981;48(4):281–8.CrossRefPubMedGoogle Scholar
  8. 8.
    Savides MC, Oehme FW, Leipold HW. Effects of various antidotal treatments on acetaminophen toxicosis and biotransformation in cats. Am J Vet Res. 1985;46(7):1485–9.PubMedGoogle Scholar
  9. 9.
    Iciek M, Polak M, Włodek L. Effect of thiol drugs on the oxidative hemolysis in human erythrocytes. Acta Pol Pharm. 2000;57(6):449–54.PubMedGoogle Scholar
  10. 10.
    Kondo H, Takahashi M, Niki E. Peroxynitrite-induced hemolysis of human erythrocytes and its inhibition by antioxidants. FEBS Lett. 1997;413(2):236–8.CrossRefPubMedGoogle Scholar
  11. 11.
    Martin L, Khalil H. How much reduced hemoglobin is necessary to generate central cyanosis? Chest. 1990;97(1):182–5.CrossRefPubMedGoogle Scholar
  12. 12.
    Finch CA. Methemoglobinemia and sulfhemoglobinemia. N Engl J Med. 1948;239(13):470–8.CrossRefPubMedGoogle Scholar
  13. 13.
    Jaffe ER, Hultquist DE. Cytochrome b5 reductase deficiency and enzymopenic hereditary methemoglobinemia. In: Scriver CR, Beaudet AL, Sly WS, et al., editors. The metabolic basis of inherited disease. New York: McGraw-Hill; 1995. p. 3399–415.Google Scholar
  14. 14.
    Kedar PS, Warang P, Ghosh K, Colah RB. Severe mental retardation and recessive congenital methemoglobinemia in three Indian patients: compound heterozygous for NADH-cytochrome b5 reductase gene mutations. Am J Hematol. 2011;86(3):327–9.CrossRefPubMedGoogle Scholar
  15. 15.
    Yano SS, Danish EH, Hsia YE. Transient methemoglobinemia with acidosis in infants. J Pediatr. 1982;100(3):415–8.CrossRefPubMedGoogle Scholar
  16. 16.
    Luk G, Riggs D, Luque M. Severe methemoglobinemia in a 3-week-old infant with a urinary tract infection. Crit Care Med. 1991;19(10):1325–7.CrossRefPubMedGoogle Scholar
  17. 17.
    Kern K, Langevin PB, Dunn BM. Methemoglobinemia after topical anesthesia with lidocaine and benzocaine for a difficult intubation. J Clin Anesth. 2000;12(2):167–72.CrossRefPubMedGoogle Scholar
  18. 18.
    Stoiber TR. Toxic methemoglobinemia complicating transesophageal echocardiography. Echocardiography. 1999;16(4):383–5.CrossRefPubMedGoogle Scholar
  19. 19.
    Schroeder TH, Dieterich HJ, Mühlbauer B. Methemoglobinemia after axillary block with bupivacaine and additional injection of lidocaine in the operative field. Acta Anaesthesiol Scand. 1999;43(4):480–2.CrossRefPubMedGoogle Scholar
  20. 20.
    Karim A, Ahmed S, Siddiqui R, Mattana J. Methemoglobinemia complicating topical lidocaine used during endoscopic procedures. Am J Med. 2001;111(2):150–3.CrossRefPubMedGoogle Scholar
  21. 21.
    Lynch A, Tobias JD. Acute valproate ingestion induces symptomatic methemoglobinemia. Pediatr Emerg Care. 1998;14(3):205–7.CrossRefPubMedGoogle Scholar
  22. 22.
    Moreira V, De Medeiros BC, Bonfim CM, Pasquini R, De Medeiros CR. Methemoglobinemia secondary to clofazimine treatment for chronic graft-versus-host disease. Blood. 1998;92(12):4872–3.PubMedGoogle Scholar
  23. 23.
    Khan AM, Singh NT, Bilgrami S. Flutamide induced methemoglobinemia. J Urol. 1997;157(4):1363.CrossRefPubMedGoogle Scholar
  24. 24.
    Hadjiliadis D, Govert JA. Methemoglobinemia after infusion of ifosfamide chemotherapy: first report of a potentially serious adverse reaction related to ifosfamide. Chest. 2000;118(4):1208–10.CrossRefPubMedGoogle Scholar
  25. 25.
    Curry SC, Arnold-Capell P. Toxic effects of drugs used in the ICU. Nitroprusside, nitroglycerin, and angiotensin-converting enzyme inhibitors. Crit Care Clin. 1991;7(3):555–81.PubMedGoogle Scholar
  26. 26.
    Lukens JN. Landmark perspective: the legacy of well-water methemoglobinemia. JAMA. 1987;257(20):2793–5.CrossRefPubMedGoogle Scholar
  27. 27.
    Centers for Disease Control and Prevention (CDC). Methemoglobinemia attributable to nitrite contamination of potable water through boiler fluid additives – New Jersey, 1992 and 1996. MMWR Morb Mortal Wkly Rep. 1997;46(9):202–4.Google Scholar
  28. 28.
    Kennedy N, Smith CP, McWhinney P. Faulty sausage production causing methaemoglobinaemia. Arch Dis Child. 1997;76(4):367–8.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Hunter L, Gordge L, Dargan PI, Wood DM. Methaemoglobinaemia associated with the use of cocaine and volatile nitrites as recreational drugs: a review. Br J Clin Pharmacol. 2011;72(1):18–26.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Centers for Disease Control and Prevention (CDC). Severe methemoglobinemia and hemolytic anemia from aniline purchased as 2C-E (4-ethyl-2,5-dimethoxyphenethylamine), a recreational drug, on the Internet – Oregon, 2011. MMWR Morb Mortal Wkly Rep. 2012;61(5):85–8.Google Scholar
  31. 31.
    Shepherd G, Grover J, Klein-Schwartz W. Prolonged formation of methemoglobin following nitroethane ingestion. J Toxicol Clin Toxicol. 1998;36(6):613–6.CrossRefPubMedGoogle Scholar
  32. 32.
    Roberts DM, Heilmair R, Buckley NA, et al. Clinical outcomes and kinetics of propanil following acute self-poisoning: a prospective case series. BMC Clin Pharmacol. 2009;9:3.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Brewer GJ, Tarlov AR, Kellermeyer RW, Alving AS. The hemolytic effect of primaquine. XV. Role of methemoglobin. J Lab Clin Med. 1962;59:905–17.PubMedGoogle Scholar
  34. 34.
    Spurzem JR, Bonekat HW, Shigeoka JW. Factitious methemoglobinemia caused by hyperlipemia. Chest. 1984;86(1):84–6.CrossRefPubMedGoogle Scholar
  35. 35.
    Kirlangitis JJ, Middaugh RE, Zablocki A, Rodriquez F. False indication of arterial oxygen desaturation and methemoglobinemia following injection of methylene blue in urological surgery. Mil Med. 1990;155(6):260–2.PubMedGoogle Scholar
  36. 36.
    Henretig FM, Gribetz B, Kearney T, Lacouture P, Lovejoy FH. Interpretation of color change in blood with varying degree of methemoglobinemia. J Toxicol Clin Toxicol. 1988;26(5–6):293–301.CrossRefPubMedGoogle Scholar
  37. 37.
    Shihana F, Dissanayake DM, Buckley NA, Dawson AH. A simple quantitative bedside test to determine methemoglobin. Ann Emerg Med. 2010;55(2):184–9.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Ralston AC, Webb RK, Runciman WB. Potential errors in pulse oximetry. III: effects of interferences, dyes, dyshaemoglobins and other pigments. Anaesthesia. 1991;46(4):291–5.CrossRefPubMedGoogle Scholar
  39. 39.
    Feiner JR, Bickler PE. Improved accuracy of methemoglobin detection by pulse CO-oximetry during hypoxia. Anesth Analg. 2010;111(5):1160–7.CrossRefPubMedGoogle Scholar
  40. 40.
    Reay DT, Insalaco SJ, Eisele JW. Postmortem methemoglobin concentrations and their significance. J Forensic Sci. 1984;29(4):1160–3.CrossRefPubMedGoogle Scholar
  41. 41.
    Steele CW, Spink WW. Methylene blue in the treatment of poisonings associated with methemoglobinemia. N Engl J Med. 1933;208(22):1152–3.CrossRefGoogle Scholar
  42. 42.
    Hartmann AF, Perley AM, Barnett HL. A study of some of the physiological effects of sulfanilamide. II. Methemoglobin formation and its control. J Clin Invest. 1938;17(6):699–710.CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Wendel WB. The control of methemoglobinemia with methylene blue. J Clin Invest. 1939;18(2):179–85.CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Herman MI, Chyka PA, Butler AY, Rieger SE. Methylene blue by intraosseous infusion for methemoglobinemia. Ann Emerg Med. 1999;33(1):111–3.CrossRefPubMedGoogle Scholar
  45. 45.
    Mier RJ. Treatment of aniline poisoning with exchange transfusion. J Toxicol Clin Toxicol. 1988;26(5–6):357–64.CrossRefPubMedGoogle Scholar
  46. 46.
    Harrison MR. Toxic methaemoglobinaemia. A case of acute nitrobenzene and aniline poisoning treated by exchange transfusion. Anaesthesia. 1977;32(3):270–2.CrossRefPubMedGoogle Scholar
  47. 47.
    Berlin G, Brodin B, Hilden JO, Mårtensson J. Acute dapsone intoxication: a case treated with continuous infusion of methylene blue, forced diuresis and plasma exchange. J Toxicol Clin Toxicol. 1984;22(6):537–48.CrossRefPubMedGoogle Scholar
  48. 48.
    Southgate HJ, Masterson R. Lessons to be learned: a case study approach: prolonged methaemoglobinaemia due to inadvertent dapsone poisoning; treatment with methylene blue and exchange transfusion. J R Soc Promot Health. 1999;119(1):52–5.CrossRefPubMedGoogle Scholar
  49. 49.
    Karadsheh NS, Shaker Q, Ratroat B. Metoclopramide-induced methemoglobinemia in a patient with co-existing deficiency of glucose-6-phosphate dehydrogenase and NADH-cytochrome b5 reductase: failure of methylene blue treatment. Haematologica. 2001;86(6):659–60.PubMedGoogle Scholar
  50. 50.
    Rosen PJ, Johnson C, McGehee WG, Beutler E. Failure of methylene blue treatment in toxic methemoglobinemia. Association with glucose-6-phosphate dehydrogenase deficiency. Ann Intern Med. 1971;75(1):83–6.CrossRefPubMedGoogle Scholar
  51. 51.
    Nadler JE, Green H, Rosenbaum A. Intravenous injection of methylene blue in man with reference to its toxic symptoms and effect on the electrocardiogram. Am J Med Sci. 1934;188(1):15–21.CrossRefGoogle Scholar
  52. 52.
    Lamont AS, Roberts MS, Holdsworth DG, Atherton A, Shepherd JJ. Relationship between methaemoglobin production and methylene blue plasma concentrations under general anaesthesia. Anaesth Intensive Care. 1986;14(4):360–4.PubMedGoogle Scholar
  53. 53.
    Stossel TP, Jennings RB. Failure of methylene blue to produce methemoglobinemia in vivo. Am J Clin Pathol. 1966;45(5):600–4.CrossRefPubMedGoogle Scholar
  54. 54.
    Way JL, Leung P, Sylvester DM. Methaemoglobin formation in the treatment of acute cyanide intoxication. In: Ballantyne B, Marrs TC, editors. Clinical and experimental toxicology of cyanides. Bristol: IOP Publishing; 1987. p. 402–12.Google Scholar
  55. 55.
    Liao YP, Hung DZ, Yang DY. Hemolytic anemia after methylene blue therapy for aniline-induced methemoglobinemia. Vet Hum Toxicol. 2002;44(1):19–21.PubMedGoogle Scholar
  56. 56.
    Kirsch IR, Cohen HJ. Heinz body hemolytic anemia from the use of methylene blue in neonates. J Pediatr. 1980;96(2):276–8.CrossRefPubMedGoogle Scholar
  57. 57.
    Crooks J. Haemolytic jaundice in a neonate after intra-amniotic injection of methylene blue. Arch Dis Child. 1982;57(11):872–3.CrossRefPubMedPubMedCentralGoogle Scholar
  58. 58.
    McEnerney JK, McEnerney LN. Unfavorable neonatal outcome after intraamniotic injection of methylene blue. Obstet Gynecol. 1983;61 Suppl 3:35S–7.PubMedGoogle Scholar
  59. 59.
    Coleman MD, Rhodes LE, Scott AK, et al. The use of cimetidine to reduce dapsone-dependent methaemoglobinaemia in dermatitis herpetiformis patients. Br J Clin Pharmacol. 1992;34(3):244–9.CrossRefPubMedPubMedCentralGoogle Scholar
  60. 60.
    Hirano M, Matsuki T, Tanishima K, et al. Congenital methaemoglobinaemia due to NADH methaemoglobin reductase deficiency: successful treatment with oral riboflavin. Br J Haematol. 1981;47(3):353–9.CrossRefPubMedGoogle Scholar
  61. 61.
    Kaplan JC, Chirouze M. Therapy of recessive congenital methaemoglobinaemia by oral riboflavine. Lancet. 1978;2(8098):1043–4.CrossRefPubMedGoogle Scholar
  62. 62.
    Wright RO, Woolf AD, Shannon MW, Magnani B. N-acetylcysteine reduces methemoglobin in an in-vitro model of glucose-6-phosphate dehydrogenase deficiency. Acad Emerg Med. 1998;5(3):225–9.CrossRefPubMedGoogle Scholar
  63. 63.
    Tanen DA, LoVecchio F, Curry SC. Failure of intravenous N-acetylcysteine to reduce methemoglobin produced by sodium nitrite in human volunteers: a randomized controlled trial. Ann Emerg Med. 2000;35(4):369–73.CrossRefPubMedGoogle Scholar
  64. 64.
    Park SY, Lee KW, Kang TS. High-dose vitamin C management in dapsone-induced methemoglobinemia. Am J Emerg Med. 2014;32(6):684.e1–e3.CrossRefGoogle Scholar
  65. 65.
    Goluboff N, Wheaton R. Methylene blue induced cyanosis and acute hemolytic anemia complicating the treatment of methemoglobinemia. J Pediatr. 1961;58:86–9.CrossRefPubMedGoogle Scholar
  66. 66.
    Chatfield MJ, La Mar GN. 1H nuclear magnetic resonance study of the prosthetic group in sulfhemoglobin. Arch Biochem Biophys. 1992;295(2):289–96.CrossRefPubMedGoogle Scholar
  67. 67.
    Park CM, Nagel RL. Sulfhemoglobinemia. Clinical and molecular aspects. N Engl J Med. 1984;310(24):1579–84.CrossRefPubMedGoogle Scholar
  68. 68.
    Curry SC, Gerkin RD. A patient with sulfhemoglobin? Ann Emerg Med. 1987;16(7):828–30.PubMedGoogle Scholar
  69. 69.
    Smith RP, Gosselin RE. Hydrogen sulfide poisoning. J Occup Med. 1979;21(2):93–7.CrossRefPubMedGoogle Scholar
  70. 70.
    Mary AM, Bhupalam L. Metoclopramide-induced methemoglobinemia in an adult. J Ky Med Assoc. 2000;98(6):245–7.PubMedGoogle Scholar
  71. 71.
    Van Veldhuizen PJ, Wyatt A. Metoclopramide-induced sulfhemoglobinemia. Am J Gastroenterol. 1995;90(6):1010–1.PubMedGoogle Scholar
  72. 72.
    Kouides PA, Abboud CN, Fairbanks VF. Flutamide-induced cyanosis refractory to methylene blue therapy. Br J Haematol. 1996;94(1):73–5.CrossRefPubMedGoogle Scholar
  73. 73.
    Chawla R, Gurnani A, Bhattacharya A. Acute dapsone poisoning. Anaesth Intensive Care. 1993;21(3):349–51.PubMedGoogle Scholar
  74. 74.
    Halvorsen SM, Dull WL. Phenazopyridine-induced sulfhemoglobinemia: inadvertent rechallenge. Am J Med. 1991;91(3):315–7.CrossRefPubMedGoogle Scholar
  75. 75.
    Azen EA, Bryan GT, Shahidi NT, Rossi EC, Clatanoff DV. Obscure hemolytic anemia due to analgesic abuse. Does enterogenous cyanosis exist? Am J Med. 1970;48(6):724–7.CrossRefPubMedGoogle Scholar
  76. 76.
    Westphal RG, Azen EA. Experimental enterogenous cyanosis and anaemia. Br J Haematol. 1972;22(5):609–16.CrossRefPubMedGoogle Scholar
  77. 77.
    Levine D, Brunton AT, Kruger A, Hersant M. Recurrent sulphaemoglobinaemia treated with neomycin. J R Soc Med. 2000;93(8):428.CrossRefPubMedPubMedCentralGoogle Scholar
  78. 78.
    Michel HO, Harris JS. The blood pigments: the properties and quantitative determination with special reference to spectrophotometric methods. J Lab Clin Med. 1940;25(5):445–63.Google Scholar
  79. 79.
    Carrico RJ, Peisach J, Alben JO. The preparation and some physical properties of sulfhemoglobin. J Biol Chem. 1978;253(7):2386–91.PubMedGoogle Scholar
  80. 80.
    Zoppi F, Brenna S, Fumagalli C, Marocchi A. Discrimination among dyshemoglobins: analytical approach to a toxicological query. Clin Chem. 1996;42(8 Pt 1):1300–2.PubMedGoogle Scholar
  81. 81.
    Demedts P, Wauters A, Watelle M, Neels H. Pitfalls in discriminating sulfhemoglobin from methemoglobin. Clin Chem. 1997;43(6 Pt 1):1098–9.PubMedGoogle Scholar
  82. 82.
    Zwart A, Buursma A, Oeseburg B, Zijlstra WG. Determination of hemoglobin derivatives with IL 282 CO-oximeter as compared with a manual spectrophotometric five-wavelength method. Clin Chem. 1981;27(11):1903–7.PubMedGoogle Scholar
  83. 83.
    Aravindhan N, Chisholm DG. Sulfhemoglobinemia presenting as pulse oximetry desaturation. Anesthesiology. 2000;93(3):883–4.CrossRefPubMedGoogle Scholar
  84. 84.
    Wu C, Kenny MA. A case of sulfhemoglobinemia and emergency measurement of sulfhemoglobin with an OSM3 CO-oximeter. Clin Chem. 1997;43(1):162–6.PubMedGoogle Scholar
  85. 85.
    Langford JS, Sheikh S. An adolescent case of sulfhemoglobinemia associated with high-dose metoclopramide and N-acetylcysteine. Ann Emerg Med. 1999;34(4 Pt 1):538–41.CrossRefPubMedGoogle Scholar
  86. 86.
    Burgess JL, Hamner AP, Robertson WO. Sulfhemoglobinemia after dermal application of DMSO. Vet Hum Toxicol. 1998;40(2):87–9.PubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  1. 1.Department of Medical ToxicologyBanner – University Medical Center PhoenixPhoenixUSA

Personalised recommendations